ここから本文です
Yahoo!ファイナンス
投稿一覧に戻る

サンバイオ(株)【4592】の掲示板 2018/11/29〜2018/11/30

A total of 18 patients were treated with SB623 cells.

All experienced at least 1 treatment-emergent adverse event (TEAE)

Seven patients experienced 9 serious adverse events, which resolved without sequelae.